These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8830332)

  • 1. Effects of a new synthetic lipid A on endogenous tumor necrosis factor production and antitumor activity against human pancreatic cancer cells.
    Satake K; Yokomatsu H; Hiura A
    Pancreas; 1996 Apr; 12(3):260-6. PubMed ID: 8830332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of lipid A on the production of tumor necrosis factor (TNF) and antitumor activity against pancreatic cancer cells: preliminary report].
    Yokomatsu H; Satake K
    Nihon Geka Gakkai Zasshi; 1992 Jul; 93(7):771. PubMed ID: 1508144
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic lipid A produces antitumor effect in a hamster pancreatic carcinoma model through production of tumor necrosis factor from activated macrophages.
    Morita S; Yamamoto M; Kamigaki T; Saitoh Y
    Kobe J Med Sci; 1996 Aug; 42(4):219-31. PubMed ID: 9023454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
    Kumazawa E; Jimbo T; Akimoto T; Joto N; Tohgo A
    Cancer Invest; 1997; 15(6):522-30. PubMed ID: 9412657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
    Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
    Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.
    Kuramitsu Y; Nishibe M; Ohiro Y; Matsushita K; Yuan L; Obara M; Kobayashi M; Hosokawa M
    Anticancer Drugs; 1997 Jun; 8(5):500-8. PubMed ID: 9215614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral production of tumor necrosis factor augmented by endogenous interferons results in potent antitumor effects of DT-5461, a synthetic lipid A analog.
    Kumazawa E; Akimoto T; Kita Y; Jimbo T; Joto N; Tohgo A
    J Immunother Emphasis Tumor Immunol; 1995 Apr; 17(3):141-50. PubMed ID: 7542128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenografts.
    Schultz RM; Merriman RL; Toth JE; Zimmermann JE; Hertel LW; Andis SL; Dudley DE; Rutherford PG; Tanzer LR; Grindey GB
    Oncol Res; 1993; 5(6-7):223-8. PubMed ID: 8123942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects.
    Yang D; Satoh M; Ueda H; Tsukagoshi S; Yamazaki M
    Cancer Immunol Immunother; 1994 May; 38(5):287-93. PubMed ID: 8162610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.
    Akimoto T; Kumazawa E; Jimbo T; Joto N; Tohgo A
    Int J Immunopharmacol; 1994 Nov; 16(11):887-93. PubMed ID: 7868293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity.
    Satoh M; Tsurumaki K; Kagehara H; Yamazaki M
    Cancer Immunol Immunother; 2002 Feb; 50(12):653-62. PubMed ID: 11862417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tumor necrosis factor in a murine tumor by systemic administration of a novel synthetic lipid A analogue, ONO-4007.
    Ueda H; Yamazaki M
    J Immunother; 1997 Jan; 20(1):65-9. PubMed ID: 9101415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of locally enhanced production of tumor necrosis factor-alpha in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007, in hepatoma-bearing rats.
    Kuramitsu Y; Ohiro Y; Matsushita K; Obara M; Kobayashi M; Hosokawa M
    Anticancer Drugs; 1997 Oct; 8(9):886-93. PubMed ID: 9402316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
    Sato T; Yamauchi N; Sasaki H; Takahashi M; Okamoto T; Sakamaki S; Watanabe N; Niitsu Y
    Cancer Res; 1998 Apr; 58(8):1677-83. PubMed ID: 9563482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
    Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharide.
    Haranaka K; Satomi N; Sakurai A; Kunii O
    Tohoku J Exp Med; 1984 Dec; 144(4):385-96. PubMed ID: 6528335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
    Matsuura M; Kiso M; Hasegawa A; Nakano M
    Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.